Researchers have demonstrated the potential of the innovative optical genome mapping (OGM) technique for the diagnosis, ...

While there is no cure for multiple myeloma, increased awareness about the symptoms can be the key to timely diagnosis and ...

A new research paper was published in Oncotarget, Volume 16, on March 21, 2025, titled “NSD2-epigenomic reprogramming and ...

Support grows for a new test designed to monitor individuals at risk of multiple myeloma, aiming for earlier detection and ...

A new research paper was published in , Volume 16, on March 21, 2025, titled "NSD2-epigenomic reprogramming and maintenance of plasma cell phenotype in t(4;14) myeloma." ...

A growing number of physicians are starting to shift their thinking about multiple myeloma’s prognosis. For years, patients have been told that multiple myeloma is treatable but not curable. Yet data ...

The abnormal accumulation of antibody-producing immune cells in the lungs may contribute to IPF progression, a new study ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Early infection incidence in patients with multiple myeloma following treatment with cilta-cel infusion highlights the ...

Multiple myeloma is a rare cancer that originates in white blood cells (plasma cells) that produce antibodies.

Our findings suggest a role for NSD2 in maintaining MM cell identity, with potential implications for future therapeutic ...